CAMPAGNOLO, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.083
EU - Europa 421
AS - Asia 403
AF - Africa 2
OC - Oceania 1
Totale 4.910
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.083
CN - Cina 215
SG - Singapore 164
IT - Italia 149
FI - Finlandia 51
SE - Svezia 50
DE - Germania 49
FR - Francia 46
GB - Regno Unito 46
UA - Ucraina 12
VN - Vietnam 12
RU - Federazione Russa 8
IN - India 6
HK - Hong Kong 3
IE - Irlanda 3
NL - Olanda 3
DZ - Algeria 2
KR - Corea 2
CH - Svizzera 1
ES - Italia 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
Totale 4.910
Salva come PNG Salva come JPEG
Città #
Fairfield 689
Woodbridge 500
Houston 365
Ann Arbor 338
Ashburn 303
Cambridge 263
Seattle 263
Wilmington 228
Chandler 205
Santa Clara 143
Singapore 136
Boardman 91
San Diego 84
Princeton 62
Medford 52
Beijing 50
Jacksonville 41
Des Moines 39
Padova 33
Roxbury 25
New York 23
Nanjing 21
Helsinki 17
Milan 13
Dong Ket 12
Hebei 12
Shenyang 10
Guangzhou 9
Rome 9
Cassano D'adda 6
Changsha 5
Haikou 5
Jiaxing 5
Jinan 5
Nanchang 5
Tianjin 5
Washington 5
Fuzhou 4
Gavirate 4
Kilburn 4
London 4
Ningbo 4
Shanghai 4
Springfield 4
Venice 4
Amsterdam 3
Bologna 3
Caserta 3
Colombes 3
Dublin 3
Falls Church 3
Hangzhou 3
Hong Kong 3
Kharkiv 3
Kunming 3
Lappeenranta 3
Livorno 3
Los Angeles 3
Miami 3
Norwalk 3
Ogden 3
Redwood City 3
Venezia 3
Auburn Hills 2
Berlin 2
Chengdu 2
Dallas 2
Düsseldorf 2
Islington 2
New Bedfont 2
Nürnberg 2
Paris 2
Praia a Mare 2
Prineville 2
Pune 2
Reggio Emilia 2
Segrate 2
Torino 2
Turin 2
Zhengzhou 2
Alessandria 1
Anyang-si 1
Boston 1
Brentford 1
Bucheon-si 1
Buffalo 1
Caorle 1
Carini 1
Cassano 1
Catania 1
Cerreto Guidi 1
Chongqing 1
Costa Mesa 1
Council Bluffs 1
Forest City 1
Frankfurt Am Main 1
Harbin 1
Hounslow 1
Huzhou 1
Lanzhou 1
Totale 4.217
Salva come PNG Salva come JPEG
Nome #
Long-term plasma exchange in pediatric CIDP. 176
Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. 151
Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias. 136
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients. 132
Disulfiram-induced peripheral and central neurotoxicity 130
Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings. 130
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 129
Reversible isolated sensory axonal neuropathy due to cobalamin deficiency. 128
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post-hoc analysis of a prospective study 121
Whipple's disease without gastrointestinal symptoms: a challenging diagnosis. 121
IgM MGUS and Waldenstromassociated anti-MAG neuropathies display similar response to rituximab therapy 120
Nerve Ultrasound findings in neuropathy associated with anti-MAG antibodies 116
Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy 115
A case of Ciguatera poisoning with paradoxical dysaesthesia and degenerative features at skin biopsy 113
Lenalidomide long-term neurotoxicity: clinical and neurophysiological prospective study. 112
Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients 112
Lenalidomide for bortezomib- resistant Multiple Myeloma 109
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study. 108
Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment. 106
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 104
Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study. 103
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 102
Multifocal neurological involvement as the only manifestation of IgG4-related disease. 100
Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies 100
Peripheral nervous system involvement in lymphomas 93
Chronic ataxic neuropathy associated with antibodies to disialogangliosides responsive to Rituximab 93
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy. 90
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 89
Novel mutation of the mitofusin 2 gene in a family with Charcot-Marie-Tooth disease type 2 (CMT2A). 87
Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed/refractory multiple myeloma: results from a single-centre prospective study. 78
Heterogeneous clinical and imaging findings and long-term prognosis in patients with neurolymphomatosis 76
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 colorectal cancer patients 72
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 72
Neurolymphomatosis, a rare manifestation of peripheral nerve involvement in lymphomas: suggestive features and diagnostic challenges 70
Long-term course of oxaliplatin-induced polyneuropathy: a prospective two-year follow-up study. 69
Nerve Ultrasound abnormalities mirrors the course of VZV sensory-motor radiculoplexopathy 67
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 67
Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies 66
PERIPHERAL NEUROPATHY CLINICAL COURSE DURING LENALIDOMIDE THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SINGLE-CENTRE PROSPECTIVE NON INTERVENTIONAL STUDY 63
Sporadic hereditary neuropathies misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: Pitfalls and red flags 63
Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies 61
Limitations in daily activities and general perception of quality of life: Long term follow-up in patients with anti-myelin-glycoprotein antibody polyneuropathy 60
Thalidomide-induced peripheral neuropathy 57
NOVEL MUTATION OF THE MITOFUSIN 2 GENE IN A FAMILY WITH CHARCOT-MARIE-TOOTH DISEASE TYPE 2A 54
NK CELLS AND NK CELL RECEPTORS IN PATIENTS WITH ANTI-MAG NEUROPATHY TREATED WITH RITUXIMAB 53
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy 53
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 53
Update on therapy of chronic immune-mediated neuropathies. 52
Indirect effects of the lockdown for the COVID-19 pandemic: Comparative study of fibular palsies from prolonged sitting posture 43
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance 36
Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease 34
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 32
Symptom recognition is impaired in patients with orthostatic hypotension 31
Skin Biopsy in Evaluation of Autonomic Disorders 31
Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function? 30
SKEWED EXPRESSION OF NATURAL KILLER (NK) CELL RECEPTORS IN PATIENTS WITH ANTI-MAG POLYNEUROPATHY 29
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 26
Diagnostic criteria for idiopathic small fiber neuropathy: A systematic review 26
Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic review 25
Rapidly progressive multiple system atrophy in a patient carrying LRRK2 G2019S mutation 23
Peripheral nerve involvement in wild-type transthyretin amyloidosis 22
Neuropatie immuno-mediate 19
Neurotransmitter and receptor systems in the subthalamic nucleus 18
Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy 15
Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid 13
The pharmacological management of the behavioral aspects of Parkinson’s disease: an update 12
Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages 10
Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort 10
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 9
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 9
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease 8
Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease 7
Totale 5.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.478
article - articoli 19.222
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 256
Totale 38.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020407 0 0 0 0 0 0 73 91 86 90 39 28
2020/20211.163 36 34 38 49 176 49 69 72 96 73 354 117
2021/2022873 64 108 92 48 20 79 50 88 58 34 72 160
2022/2023447 91 21 13 41 93 51 2 41 51 3 32 8
2023/2024372 12 34 42 37 35 63 38 10 14 12 31 44
2024/2025524 9 105 72 57 251 28 2 0 0 0 0 0
Totale 5.050